Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GE HealthCare Technologies Inc. - Common Stock (NQ: GEHC )

79.17 -0.27 (-0.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,208,118
Open 79.83
Bid (Size) 77.32 (1)
Ask (Size) 79.49 (1)
Prev. Close 79.44
Today's Range 78.49 - 80.10
52wk Range 62.35 - 94.50
Shares Outstanding N/A
Dividend Yield 0.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is It Too Late to Buy GE Aerospace Stock?
The aerospace company has a dominant market position and a runway for long-term growth, but it is priced at a premium. 
Via The Motley Fool
GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology
From GE HealthCare
Via Business Wire

Performance

YTD
+3.67%
+3.67%
1 Month
-1.80%
-1.80%
3 Month
-11.77%
-11.77%
6 Month
+2.05%
+2.05%
1 Year
-1.30%
-1.30%

More News

Read More
(GEHC) - Analyzing GE HealthCare Techs's Short Interest
Via Benzinga
If You'd Invested $10,000 in General Electric (Now GE Aerospace) Stock 5 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Expert Ratings For GE HealthCare Techs
Via Benzinga
Why Shares in GE Healthcare Looked Sick This Week
Via The Motley Fool
GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers
From GE HealthCare
Via Business Wire
GE Stock Soars In 2024 On Strong Jet Engine Demand. Is GE Aerospace A Buy?
Via Investor's Business Daily
GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World
From GE HealthCare
Via Business Wire
GE HealthCare Pharmaco-Economic Study Demonstrates Adding Breast Oncology PET Tracer to Standard Workup of Patients with Metastatic or Recurrent Breast Cancer May Yield Beneficial Clinical and Economic Outcomes, Potentially Saving $142M Over Five...
From GE HealthCare
Via Business Wire
General Electric: The Re-Constituted And Re-Invigorated Dividend Play
Via Talk Markets
Topics Economy
Exposures Economy
Nvidia, GE HealthCare Technologies And A Video Streaming Giant On CNBC's 'Final Trades'
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
GE HealthCare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida
From GE HealthCare
Via Business Wire
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
Spinoff Speed Demons: How Much Further Can These 3 Stocks Run?
Via InvestorPlace
S&P 500 Plays And One Dow Jones Giant Lead Five Stocks Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations
From GE HealthCare
Via Business Wire
GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease
From GE HealthCare
Via Business Wire
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Via InvestorPlace
Topics ETFs
GE Aerospace Soars 110% To 15-Year High — Is GE Stock A Buy?
Via Investor's Business Daily
GE HealthCare to Hold an Investor Day in New York City on November 21, 2024
From GE HealthCare
Via Business Wire
Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?
Via InvestorPlace
Last Week's Worst-Performing Stocks: Are These 15 Large-Cap Stocks In Your Portfolio? (April 28-May 4, 2024)
Via Benzinga
Pushing the Boundaries of Neuroscience with GE HealthCare’s SIGNA MAGNUS
From GE HealthCare
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.